Internal Medicine, Rheumatology · Huntsville, TX
NPI
1588691026
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
116 Medical Park Ln Ste B
Huntsville, TX, 77340
Phone (936) 215-6418
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
95,023 services
Medicare patients, 2024
330
Average age 73
Drug cost, 2024
$6.8M
4,341 prescriptions
Company payments, 2025
$1,362
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anil Warrier was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 33,200 times for 13 patients. In total Anil Warrier billed 95,023 services in 53 codes, and Medicare paid $1.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-10.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 33,200 | 13 | $3.62 | $120K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 12,390 | 12 | $8.46 | $105K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 7,850 | 12 | $8.82 | $69K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 6,300 | 11 | $33.87 | $213K |
| J0897 Injection, denosumab, 1 mg | Office | 5,040 | 59 | $20.65 | $104K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 877 | 20 | $0.22 | $190 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 540 | 252 | $11.81 | $6,380 |
| 99214 Office E&M - Established | Office | 503 | 233 | $87.29 | $44K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 311 | 44 | $0.73 | $228 |
| 96413 Chemotherapy Administration | Office | 249 | 44 | $87.66 | $22K |
| 96401 Chemotherapy Administration | Office | 204 | 60 | $51.80 | $11K |
| 96367 Intravenous Infusion, Hydration | Office | 190 | 30 | $20.56 | $3,906 |
| 96372 Injection Administration | Office | 176 | 49 | $9.88 | $1,738 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 95 | 22 | $0.64 | $60.61 |
| 96415 Chemotherapy Administration | Office | 85 | 14 | $19.19 | $1,631 |
By year: 2022 $2.0M for 89,449 services; 2023 $1.1M for 92,793 services; 2024 $1.0M for 95,023 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anil Warrier prescribed most often to Medicare patients was Prednisone, with 593 prescriptions and refills. In total Anil Warrier wrote 4,341 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 593 | 1,336 | 203 | $4,546 |
| Hydroxychloroquine Sulfate Generic | 480 | 1,174 | 157 | $23K |
| Methotrexate Methotrexate Sodium | 473 | 1,116 | 158 | $11K |
| Leflunomide Generic | 222 | 549 | 83 | $12K |
| Gabapentin Generic | 200 | 365 | 63 | $3,828 |
| Humira(Cf) Pen Adalimumab | 132 | 144 | 22 | $1.2M |
| Enbrel Sureclick Etanercept | 112 | 118 | 18 | $928K |
| Tizanidine Hcl Generic | 106 | 149 | 33 | $1,292 |
| Pregabalin Generic | 100 | 158 | 31 | $1,651 |
| Ibandronate Sodium Generic | 90 | 252 | 35 | $2,979 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 86 | 86 | 21 | $1,399 |
| Sulfasalazine Generic | 85 | 183 | 23 | $3,056 |
| Rinvoq Upadacitinib | 79 | 93 | Under 11 | $611K |
| Celecoxib Generic | 73 | 129 | 27 | $4,025 |
| Duloxetine Hcl Generic | 68 | 142 | 25 | $1,486 |
Brand drugs: - claims; generic drugs: 3,308 claims; opioid claims: 192.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anil Warrier $1,362 ($1,362 in general payments such as food, travel and fees) from 15 companies. The largest payer was Amgen Inc. with $449.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 23 | $449 |
| UCB, Inc. UCB.BR | 6 | $172 |
| Abbvie Inc. ABBV | 6 | $141 |
| Janssen Biotech, Inc. JNJ | 6 | $112 |
| ANI Pharmaceuticals, Inc. ANIP | 5 | $103 |
| GlaxoSmithKline, LLC. GSK | 5 | $84.79 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $73.7 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $65.99 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $31.63 |
| Kyowa Kirin, Inc. 4151.T | 1 | $27.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.